Topics
- The molecular pathways in vascular biology, immunology and stromal compartments in different indications including cancer
- The role of microenvironment and immune crosstalk in different pathological situations
- Novel targets that can overcome therapy resistances as a potential target for future cancer therapy
- The importance of angiogenesis in cancer progression and metastasis
- Novel technologies related to nanotechnology and synthetic biology
- The therapeutic potential of anti-stromal molecules and translate basic science to clinical applications
Who should Attend
Basic scientists, clinician scientists, oncology specialists, vascular specialists and industry partners involved or interested in:
- Immune therapy
- Tumor microenvironment
- Targeted therapy
- Anti-angiogenesis
